Evogene Ltd
EVGN1.380USD
-0.140-9.21%
Close 06/13, 16:00（ET）Quotes delayed by 15 min
9.21MMarket Cap
LossP/E TTM
More Details of Evogene Ltd Company
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
Ticker SymbolEVGN
Company nameEvogene Ltd
IPO dateJun 11, 2007
Founded at1999
CEODr. Arnon Heyman
Number of employees117
Security typeOrdinary Share
Fiscal year-endJun 11
Address13 Gad Feinstein Street
CityREHOVOT
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code7638517
Phone97289311900
Websitehttps://evogene.com/
Ticker SymbolEVGN
IPO dateJun 11, 2007
Founded at1999
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Kenny Green
Kenny Green
Investor Relations
Investor Relations
--
--
Ms. Dorit Kreiner
Ms. Dorit Kreiner
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dan Michael Falk
Mr. Dan Michael Falk
Independent Director
Independent Director
--
--
Dr. Brian Ember
Dr. Brian Ember
Chief Executive Officer of AgPlenus Limited
Chief Executive Officer of AgPlenus Limited
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Independent Director
Independent Director
83.89K
--
Dr. Arnon Heyman
Dr. Arnon Heyman
Chief Executive Officer of Canonic Limited
Chief Executive Officer of Canonic Limited
--
--
Mr. Ofer Haviv
Mr. Ofer Haviv
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Dr. Adrian Percy
Dr. Adrian Percy
Independent Director
Independent Director
--
--
Ms. Sarit Firon
Ms. Sarit Firon
Independent Director
Independent Director
--
--
Dr. Oded Shoseyov, Ph.D.
Dr. Oded Shoseyov, Ph.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Other
4.00M
47.00%
United States
3.92M
46.00%
Israel
595.77K
7.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
4.74%
Recanati (Leon Yehuda)
1.26%
Jane Street Capital, L.L.C.
0.51%
UBS Financial Services, Inc.
0.28%
Morgan Stanley & Co. LLC
0.22%
Other
93.00%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
4.74%
Recanati (Leon Yehuda)
1.26%
Jane Street Capital, L.L.C.
0.51%
UBS Financial Services, Inc.
0.28%
Morgan Stanley & Co. LLC
0.22%
Other
93.00%
Shareholder Types
Shareholders
Proportion
Hedge Fund
4.94%
Individual Investor
1.26%
Research Firm
0.93%
Investment Advisor
0.44%
Venture Capital
0.15%
Investment Advisor/Hedge Fund
0.06%
Other
92.22%
Institutional Shareholding
Updated: Mon, Feb 24
Updated: Mon, Feb 24
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
54
511.12K
7.85%
-247.01K
2024Q4
56
495.82K
9.24%
-272.31K
2024Q3
56
646.41K
12.68%
+45.84K
2024Q2
57
498.30K
80.86%
-140.56K
2024Q1
62
510.64K
10.05%
-122.17K
2023Q4
69
544.86K
11.19%
-474.65K
2023Q3
76
590.60K
14.30%
-53.35K
2023Q2
75
185.66K
4.46%
-461.57K
2023Q1
80
194.62K
4.68%
-499.69K
2022Q4
84
224.28K
5.44%
-1.02M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
298.28K
5.56%
+103.59K
+53.21%
Dec 31, 2024
Recanati (Leon Yehuda)
83.89K
1.56%
--
--
Mar 17, 2024
Jane Street Capital, L.L.C.
21.34K
0.4%
+21.34K
--
Dec 31, 2024
UBS Financial Services, Inc.
22.01K
0.41%
+13.41K
+155.92%
Dec 31, 2024
Morgan Stanley & Co. LLC
14.56K
0.27%
+1.98K
+15.74%
Dec 31, 2024
Two Sigma Investments, LP
11.16K
0.21%
+11.16K
--
Dec 31, 2024
BNP Paribas Securities Corp. North America
12.82K
0.24%
+619.00
+5.07%
Dec 31, 2024
P&S Vermögensberatungs AG Performance & Sicherheit
10.00K
0.19%
--
--
Dec 31, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Date
Type
Ratio
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
Aug 03, 2022
Merger
10<1
